Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients

被引:121
作者
Kurashima, K
Mukaida, N
Fujimura, M
Yasui, M
Nakazumi, Y
Matsuda, T
Matsushima, K
机构
[1] KANAZAWA UNIV,SCH MED,DEPT INTERNAL MED 3,KANAZAWA,ISHIKAWA 920,JAPAN
[2] KANAZAWA UNIV,CANC RES INST,DEPT PHARMACOL,KANAZAWA,ISHIKAWA 920,JAPAN
[3] ASANOGAWA GEN HOSP,DEPT INTERNAL MED,KANAZAWA,ISHIKAWA,JAPAN
[4] UNIV TOKYO,GRAD SCH MED,DEPT MOL PREVENT MED,TOKYO,JAPAN
关键词
D O I
10.1164/ajrccm.155.4.9105097
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In pulmonary tuberculosis, the proportion of lymphocytes, particularly that of CD4(+) T lymphocytes was increased in bronchoalveolar lavage fluid (BALF), reflecting their protective role against mycobacterial infections. In order to elucidate the mechanisms of lymphocyte accumulation in lungs, we measured the levels of chemokines with potent lymphocyte chemotactic activities, including interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and, regulated on activation, normal T-cell expressed and secreted (RANTES) present in BALF from patients with pulmonary tuberculosis in acute (n = 10) and convalescent phases (n = 6), as well as normal subjects (n = 10). During the acute phase of the disease, the proportions of lymphocytes and neutrophils were increased, as reported in previous studies. The levels of IL-8, MCP-1, and RANTES in the acute phase of pulmonary tuberculosis were also markedly elevated as compared with those of normal subjects. MCP-1 and RANTES, but not IL-8 levels present in BALF, decreased in the convalescent phase. Moreover, the concentration of RANTES correlated significantly with the absolute number of CD4(+) cells in BALF. These data suggest that chemotactic cytokines are differentially produced and participate in the host response to Mycobacterium tuberculosis infection.
引用
收藏
页码:1474 / 1477
页数:4
相关论文
共 22 条
  • [1] LYMPHOCYTE AND LYMPHOCYTE SUBSET NUMBERS IN BLOOD AND IN BRONCHOALVEOLAR LAVAGE AND PLEURAL FLUID IN VARIOUS FORMS OF HUMAN PULMONARY TUBERCULOSIS AT PRESENTATION AND DURING RECOVERY
    AINSLIE, GM
    SOLOMON, JA
    BATEMAN, ED
    [J]. THORAX, 1992, 47 (07) : 513 - 518
  • [2] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
  • [3] BARNS PF, 1989, J IMMUNOL, V145, P1114
  • [4] Expression of RANTES in human airway epithelial cells: Effect of corticosteroids and interleukin-4, -10 and -13
    Berkman, N
    Robichaud, A
    Krishnan, VL
    Roesems, G
    Robbins, R
    Jose, PJ
    Barnes, PJ
    Chung, KF
    [J]. IMMUNOLOGY, 1996, 87 (04) : 599 - 603
  • [5] COSTABEL U, 1987, AM REV RESPIR DIS, V13, pA373
  • [6] BRONCHOALVEOLAR LAVAGE CYTOLOGY AND IMMUNOCYTOLOGY IN PULMONARY TUBERCULOSIS
    HOHEISEL, GB
    TABAK, L
    TESCHLER, H
    ERKAN, F
    KROEGEL, C
    COSTABEL, U
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (02) : 460 - 463
  • [7] CYTOKINE RANTES RELEASED BY THROMBIN-STIMULATED PLATELETS IS A POTENT ATTRACTANT FOR HUMAN EOSINOPHILS
    KAMEYOSHI, Y
    DORSCHNER, A
    MALLET, AI
    CHRISTOPHERS, E
    SCHRODER, JM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (02) : 587 - 592
  • [8] SELECTIVE EXPRESSION OF MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN HUMAN BLOOD MONOCYTES BY MYCOBACTERIUM-TUBERCULOSIS
    KASAHARA, K
    TOBE, T
    TOMITA, M
    MUKAIDA, N
    SU, SB
    MATSUSHIMA, K
    YOSHIDA, T
    SUGIHARA, S
    KOBAYASHI, K
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) : 1238 - 1247
  • [9] KAUFMANN SHE, 1989, REV INFECT DIS, V11, pS448
  • [10] EFFECT OF THROMBOXANE A(2) SYNTHETASE INHIBITOR, OKY-046, ON SPUTUM IN CHRONIC-BRONCHITIS AND DIFFUSE PANBRONCHIOLITIS
    KURASHIMA, K
    FUJIMURA, M
    HOYANO, Y
    TAKEMURA, K
    MATSUDA, T
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (10) : 1705 - 1711